Literature DB >> 2914900

Evidence for an imipramine-sensitive serotonin transporter in human placental brush-border membranes.

D F Balkovetz1, C Tiruppathi, F H Leibach, V B Mahesh, V Ganapathy.   

Abstract

Serotonin is actively transported into brush-border membrane vesicles isolated from normal human term placentas and an inward-directed NaCl gradient provides the driving force for this process. Uptake is negligible if Na+ is replaced by Li+, K+, Rb+, Cs+ or choline. The presence of Cl- seems necessary for the maximal activity of this Na+-dependent uptake system. Intravesicular K+ (20-40 mM) stimulates serotonin uptake, the stimulation being considerably greater at pH 7.5 than at pH 6.5. But, in the absence of K+, uptake at pH 6.5 was twice the uptake at pH 7.5. Unlabeled serotonin and dopamine inhibit the uptake of radiolabeled serotonin and the IC50 values are 70 nM and 20 microM, respectively. Histamine and 5-hydroxytryptophan do not significantly interact with the system (IC50 greater than 1 mM). Kinetic analysis reveals that serotonin uptake in these vesicles occurs via a single, saturable, high affinity system (Kt = 51 +/- 2 nM; Vmax = 6.4 +/- 0.1 pmol/mg of protein/15 s). The transporter is highly sensitive to inhibition by imipramine (IC50 = 32 nM) and desipramine (IC50 = 160 nM) but relatively insensitive to reserpine and hydralazine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2914900

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  The state of the serotonin transporter protein in the platelets of patients with somatoform [correction of somatiform] disorders.

Authors:  A R Belous; S Ramamoorthy; R D Blakely; M I Factor; A M Dupin; A B Katasonov; R H Lozier; A G Beniashvili; M A Morozova; O S Brusov
Journal:  Neurosci Behav Physiol       Date:  2001 Mar-Apr

2.  Reconstitution of the human placental 5-hydroxytryptamine transporter in a catalytically active form after detergent solubilization.

Authors:  S Ramamoorthy; D R Cool; F H Leibach; V B Mahesh; V Ganapathy
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

3.  Association of MAOA, 5-HTT, and NET promoter polymorphisms with gene expression and protein activity in human placentas.

Authors:  Huiping Zhang; Graeme N Smith; Xudong Liu; Jeanette J A Holden
Journal:  Physiol Genomics       Date:  2010-03-23       Impact factor: 3.107

Review 4.  Bioenergetics of neurotransmitter transport.

Authors:  G Rudnick
Journal:  J Bioenerg Biomembr       Date:  1998-04       Impact factor: 2.945

5.  Identification of serotonin transporter mRNA in rat platelets.

Authors:  D Hranilović; K P Lesch; D Ugarković; L Cicin-Sain; B Jernej
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

6.  Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.

Authors:  S Ramamoorthy; A L Bauman; K R Moore; H Han; T Yang-Feng; A S Chang; V Ganapathy; R D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

Review 7.  Physiological genomics of antidepressant targets: keeping the periphery in mind.

Authors:  R D Blakely
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

8.  Enhanced activity of human serotonin transporter variants associated with autism.

Authors:  Harish C Prasad; Jennifer A Steiner; James S Sutcliffe; Randy D Blakely
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-27       Impact factor: 6.237

9.  Prenatal exposure to environmental tobacco smoke alters gene expression in the developing murine hippocampus.

Authors:  Partha Mukhopadhyay; Kristin H Horn; Robert M Greene; M Michele Pisano
Journal:  Reprod Toxicol       Date:  2009-12-05       Impact factor: 3.143

10.  The serotonergic system: its role in pathogenesis and early developmental treatment of autism.

Authors:  D I Zafeiriou; A Ververi; E Vargiami
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.